Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR

Next Generation Sequencing (NGS) has become powerful tool in molecular oncology. It allows multiparallel targeted sequencing that enables comprehensive assessment of tumor heterogeneity. Detection of mutations in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) defines patients diagnos...

Full description

Bibliographic Details
Main Authors: Lana Salihefendić, Dino Pećar, Rijad Konjhodžić
Format: Article
Language:English
Published: University of Sarajevo, Institute for Genetic Engineering and Biotechnology 2019-06-01
Series:Genetics & Applications
Online Access:http://www.genapp.ba/index.php/genapp/article/view/90
_version_ 1818141132643631104
author Lana Salihefendić
Dino Pećar
Rijad Konjhodžić
author_facet Lana Salihefendić
Dino Pećar
Rijad Konjhodžić
author_sort Lana Salihefendić
collection DOAJ
description Next Generation Sequencing (NGS) has become powerful tool in molecular oncology. It allows multiparallel targeted sequencing that enables comprehensive assessment of tumor heterogeneity. Detection of mutations in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) defines patients diagnosis, therapy and prognosis. Multiple genes, their somatic mutations to be precise, carry different degrees of importance for any of these stages. Ion AmpliSeq™ Colon and Lung Cancer Research Panel v2, which was used in this study, allows detection of hotspot mutations on 22 genes in a single reaction. Droplet digital PCR (ddPCR) has a unique advantage in low frequency mutation detection and it has been used as a validation method for mutations that were detected with NGS. It has high sensitivity and enables accurate detection of mutant allele in a background of abundant wild type alleles. For this study 35 samples of CRC and NSCLC were sequenced and same samples were analysed on ddPCR for KRAS, NRAS, EGFR and BRAF genes. All processed samples were successfully sequenced and had average base coverage >500X. NGS sequencing proved itself to be cost effective, has shorter turnaround time and is highly sensitive. Out of 35 samples, 25 had genetic alterations, while 10 samples are reported as wild type but were still tested on ddPCR as controls. In three samples low frequency somatic mutations were detected by NGS and verified using ddPCR, which leads us to conclusion that ddPCR is a good tool for verification of somatic mutations in CRC and NSCLC.
first_indexed 2024-12-11T10:55:01Z
format Article
id doaj.art-8db1289fa7a44036ba263ba4440206ff
institution Directory Open Access Journal
issn 2566-2937
2566-431X
language English
last_indexed 2024-12-11T10:55:01Z
publishDate 2019-06-01
publisher University of Sarajevo, Institute for Genetic Engineering and Biotechnology
record_format Article
series Genetics & Applications
spelling doaj.art-8db1289fa7a44036ba263ba4440206ff2022-12-22T01:10:07ZengUniversity of Sarajevo, Institute for Genetic Engineering and BiotechnologyGenetics & Applications2566-29372566-431X2019-06-0131717610.31383/ga.vol3iss1pp71-7690Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCRLana Salihefendić0Dino Pećar1Rijad Konjhodžić2ALEA Genetic Center, Sarajevo, Bosnia and HerzegovinaALEA Genetic Center, Sarajevo, Bosnia and HerzegovinaALEA Genetic Center, Sarajevo, Bosnia and HerzegovinaNext Generation Sequencing (NGS) has become powerful tool in molecular oncology. It allows multiparallel targeted sequencing that enables comprehensive assessment of tumor heterogeneity. Detection of mutations in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) defines patients diagnosis, therapy and prognosis. Multiple genes, their somatic mutations to be precise, carry different degrees of importance for any of these stages. Ion AmpliSeq™ Colon and Lung Cancer Research Panel v2, which was used in this study, allows detection of hotspot mutations on 22 genes in a single reaction. Droplet digital PCR (ddPCR) has a unique advantage in low frequency mutation detection and it has been used as a validation method for mutations that were detected with NGS. It has high sensitivity and enables accurate detection of mutant allele in a background of abundant wild type alleles. For this study 35 samples of CRC and NSCLC were sequenced and same samples were analysed on ddPCR for KRAS, NRAS, EGFR and BRAF genes. All processed samples were successfully sequenced and had average base coverage >500X. NGS sequencing proved itself to be cost effective, has shorter turnaround time and is highly sensitive. Out of 35 samples, 25 had genetic alterations, while 10 samples are reported as wild type but were still tested on ddPCR as controls. In three samples low frequency somatic mutations were detected by NGS and verified using ddPCR, which leads us to conclusion that ddPCR is a good tool for verification of somatic mutations in CRC and NSCLC.http://www.genapp.ba/index.php/genapp/article/view/90
spellingShingle Lana Salihefendić
Dino Pećar
Rijad Konjhodžić
Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
Genetics & Applications
title Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
title_full Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
title_fullStr Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
title_full_unstemmed Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
title_short Validation of CRC and NSCLC somatic mutations detected by NGS using ddPCR
title_sort validation of crc and nsclc somatic mutations detected by ngs using ddpcr
url http://www.genapp.ba/index.php/genapp/article/view/90
work_keys_str_mv AT lanasalihefendic validationofcrcandnsclcsomaticmutationsdetectedbyngsusingddpcr
AT dinopecar validationofcrcandnsclcsomaticmutationsdetectedbyngsusingddpcr
AT rijadkonjhodzic validationofcrcandnsclcsomaticmutationsdetectedbyngsusingddpcr